<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30043922</article-id><article-id pub-id-type="pmc">6089127</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2017-0206</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Update in Heart Rhythm Abnormalities and Indications for Pacemaker
After Transcatheter Aortic Valve Implantation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Saadi</surname><given-names>Marina</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Tagliari</surname><given-names>Ana Paula</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="c1"/><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Danzmann</surname><given-names>Luiz Cl&#x000e1;udio</given-names></name><xref ref-type="aff" rid="aff3">3</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Bartholomay</surname><given-names>Eduardo</given-names></name><xref ref-type="aff" rid="aff3">3</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Kochi</surname><given-names>Adriano Nunes</given-names></name><xref ref-type="aff" rid="aff4">4</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Saadi</surname><given-names>Eduardo Keller</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD, MSc, PhD</role></contrib></contrib-group><aff id="aff1">
<label>1</label>Universidade Luterana do Brasil (ULBRA), Canoas, RS, Brazil.</aff><aff id="aff2">
<label>2</label>Department of Cardiovascular Surgery, Hospital de Cl&#x000ed;nicas de
Porto Alegre (HCPA), Universidade Federal do Rio Grande do Sul (UFRGS), Porto
Alegre, RS, Brazil.</aff><aff id="aff3">
<label>3</label>Department of Cardiology, Universidade Luterana do Brasil (ULBRA),
Canoas, RS, Brazil.</aff><aff id="aff4">
<label>4</label>Department of Cardiology, Hospital de Cl&#x000ed;nicas de Porto
Alegre (HCPA), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS,
Brazil.</aff><author-notes><corresp id="c1">Correspondence Address: Ana Paula Tagliari, Rua Ramiro Barcelos,
2350 - Porto Alegre, RS, Brasil, Zip Code: 90035-903. E-mail:
<email>anapaulatagliari@yahoo.com.br</email> or
<email>atagliari@hcpa.edu.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>May-Jun</season><year>2018</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>May-Jun</season><year>2018</year></pub-date><volume>33</volume><issue>3</issue><fpage>286</fpage><lpage>290</lpage><history><date date-type="received"><day>24</day><month>10</month><year>2017</year></date><date date-type="accepted"><day>20</day><month>12</month><year>2017</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><p>Objective: Rhythm abnormalities following transcatheter aortic valve implantation
(TAVI) and indications for permanent pacemaker implantation (PPI) were reviewed,
which aren't well established in the current guidelines. New left bundle branch
block and atrioventricular block are the most common electrocardiographic
changes after TAVI. PPI incidence ranges from 9-42% for self-expandable and
2.5-11.5% for balloon expandable devices. Not only anatomical variations in
conduction system have an important role in conduction disorders, but different
valve characteristics and their relationship with cardiac structures as well.
Previous right bundle branch block has been confirmed as one of the most
significant predictors for PPI.</p></abstract><kwd-group><kwd>Aortic Valve Stenosis</kwd><kwd>Transcatheter Aortic Valve Implantation</kwd><kwd>Arrhythmias, Cardiac</kwd><kwd>Pacemaker, Artificial</kwd></kwd-group></article-meta></front><body><table-wrap id="t2" orientation="portrait" position="float"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AoS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Aortic valve
stenosis</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AV</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Atrioventricular</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AVB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Atrioventricular
block</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Confidence interval</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ECG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Electrocardiogram</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">EPS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Electrophysiological
study</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">HR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Hazard ratio</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LAHB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Left anterior
hemiblock</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LBBB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Left bundle branch
block</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LVOT</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Left ventricular outflow
tract</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">OR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Odds ratio</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PPI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Permanent pacemaker
implantation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">RBBB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Right bundle branch
block</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">RR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Relative risk</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SAVR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Surgical aortic valve
replacement</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">TAVI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Transcatheter aortic
valve implantation</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Increased life expectancy has contributed to making cardiac valve diseases more
frequent and relevant<sup>[</sup><sup><xref rid="r1" ref-type="bibr">1</xref></sup><sup>]</sup>.</p><p>Aortic valve stenosis (AoS), the most common cardiac valve disease, affects
approximately 3% of the population older than 75 years<sup>[</sup><sup><xref rid="r2" ref-type="bibr">2</xref></sup><sup>]</sup> and, usually, remains
silent for many years.</p><p>However, once symptoms are present, survival decreases
dramatically<sup>[</sup><sup><xref rid="r3" ref-type="bibr">3</xref></sup><sup>,</sup><sup><xref rid="r4" ref-type="bibr">4</xref></sup><sup>]</sup>, being surgical treatment the therapy of
choice<sup>[</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>]</sup>.</p><p>Since the first clinical report in 2002, transcatheter aortic valve implantation
(TAVI) has emerged as a valuable, less invasive and safe therapeutic alternative in
patients with symptomatic severe AoS<sup>[</sup><sup><xref rid="r6" ref-type="bibr">6</xref></sup><sup>]</sup>.</p><p>Currently, TAVI is considered the gold standard for high-risk patients, the only
option for inoperable ones, and, recently, non-inferior to conventional surgery in
intermediate risk patients<sup>[</sup><sup><xref rid="r7" ref-type="bibr">7</xref></sup><sup>-</sup><sup><xref rid="r9" ref-type="bibr">9</xref></sup><sup>]</sup>.</p><p>On the other hand, this is not a risk-free procedure, with atrioventricular (AV)
conduction disturbances being a common complication<sup>[</sup><sup><xref rid="r10" ref-type="bibr">10</xref></sup><sup>]</sup>.</p><p>In this context, understanding post-procedural conduction disturbances' mechanisms
and rates is an extremely current and relevant issue.</p><p>This study aims to review rhythm abnormalities after TAVI, besides the permanent
pacemaker implantation (PPI) indications, which are not well established by the
current guidelines.</p><sec><title>Rhythm Abnormalities</title><p>Bradyarrhythmias are not uncommon after cardiac surgery, TAVI and heart
transplantation. According to the 2013 European Society of Cardiology guidelines
on cardiac pacing and cardiac resynchronization therapy<sup>[</sup><sup><xref rid="r11" ref-type="bibr">11</xref></sup><sup>]</sup>, complete
atrioventricular block (AVB) may occur in 1-4% of cardiac surgeries, 8% of
repeat valve surgeries and up to 20-24% of interventions for calcified AoS or
tricuspid valve replacement.</p><p>Following TAVI, new left bundle branch block (LBBB) and AVB are the main
electrocardiographic changes and the consequent need for a permanent pacemaker
is the most expensive short-term adverse event<sup>[</sup><sup><xref rid="r12" ref-type="bibr">12</xref></sup><sup>]</sup>.</p><p>The incidence of post-procedural conduction disturbances varies among studies,
being 20% in complete AVB, 7% to 83% in LBBB, 2% in right bundle branch block
(RBBB) and 2% in left anterior hemiblock (LAHB)<sup>[</sup><sup><xref rid="r13" ref-type="bibr">13</xref></sup><sup>-</sup><sup><xref rid="r16" ref-type="bibr">16</xref></sup><sup>]</sup>.</p><p>By Urena et al.<sup>[</sup><sup><xref rid="r13" ref-type="bibr">13</xref></sup><sup>]</sup>, 37.7% of these new LBBB are resolved before
hospital discharge and 57% in 6-12-month follow-up period.</p><p>The PARTNER trial analysis showed that, although new LBBB has not been associated
with increased 1-year mortality, it was associated with a higher in-hospital
pacemaker indication [8.3% <italic>versus</italic> 2.8%;
<italic>P</italic>=0.005] and from discharge to one year (4.7%
<italic>vs</italic>. 1.5%; <italic>P</italic>=0.01), as well as failure to
improve left ventricular ejection fraction (52.8 <italic>vs.</italic> 58.1%;
<italic>P</italic>&#x0003c;0.001)<sup>[</sup><sup><xref rid="r17" ref-type="bibr">17</xref></sup><sup>]</sup>.</p><p>In contrast, another study showed new LBBB as an independent predictor of
all-cause mortality [hazard ratio (HR) 1.54; 95% confidence interval (CI) 1.12 -
2.10]. Cardiovascular mortality rate was 9.4% for patients without TAVI-induced
LBBB and 18% for new LBBB<sup>[</sup><sup><xref rid="r15" ref-type="bibr">15</xref></sup><sup>]</sup>.</p><p>Similarly, for Makki et al.<sup>[</sup><sup><xref rid="r18" ref-type="bibr">18</xref></sup><sup>]</sup>, PPI has been associated with increased
short- and long-term mortality, which may represent inherent conduction
abnormality or pacemaker operation morbidity.</p></sec><sec><title>PPI Indications</title><p>Pacemaker implantation after TAVI has had the same recommendations as
non-surgical patients with persistent bradycardia, such as symptomatic
bradycardia, complete AVB, type II second-degree AVB, new LBBB in combination
with infra-hisian conduction delay (HV interval &#x02265;70 ms or second or
third-degree Hiss-Purkinje block)<sup>[</sup><sup><xref rid="r11" ref-type="bibr">11</xref></sup><sup>]</sup>.</p><p>The 2013 European Society of Cardiology guideline considers indication class I,
level C "high degree or complete AVB after cardiac surgery and TAVI, with a
period of clinical observation up to 7 days (<xref rid="t1" ref-type="table">Table 1</xref>). In case of complete AVB with a low rate of escape rhythm,
this observation period can be shortened since the resolution is
unlikely"<sup>[</sup><sup><xref rid="r11" ref-type="bibr">11</xref></sup><sup>]</sup>.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Recommendation for pacing after transcatheter aortic valve
implantation<sup>[</sup><sup><xref rid="r11" ref-type="bibr">11</xref></sup><sup>]</sup>.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="60%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Recommendation</th><th align="center" rowspan="1" colspan="1">Class of recommendation</th><th align="center" rowspan="1" colspan="1">Level</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">I) High degree or complete AV block after TAVI</td><td align="center" rowspan="1" colspan="1">I</td><td align="center" rowspan="1" colspan="1">C</td></tr></tbody></table></table-wrap><p>In the post-TAVI phase, the management depends on the prosthesis implanted. For
instance, early removal of the temporary pacing lead seems to be safe after the
balloon expandable Edwards Sapien&#x000ae; prosthesis, in the absence of
intraprocedural advanced degree blocks. Then, a 24-48 hour electrocardiographic
monitoring followed by a daily 12-leads electrocardiogram (ECG) until the
discharge is recommended. On the contrary, when a self-expandable
CoreValve&#x000ae; prosthesis is chosen, a 48-72 hour monitoring before removal
of the temporary pacing lead might be recommended even when the ECG early after
TAVI is normal<sup>[</sup><sup><xref rid="r19" ref-type="bibr">19</xref></sup><sup>]</sup>.</p><p>QRS duration is another factor that may assist the decision about early or late
pacing lead removal. According to a Takahashi's et al.<sup>[</sup><sup><xref rid="r20" ref-type="bibr">20</xref></sup><sup>]</sup> study, in which
patients with QRS duration &#x0003c;120 ms were submitted to early pacing lead
removal and those with QRS &#x02265;120 ms to late removal, no PPI was indicated
in the first group, while 39% of the latter developed a delayed AVB
(<italic>P</italic>=0.0001).</p><p>Taking into account that TAVI is routinely performed under heparin
anticoagulation, which potentially may lead to an increased bleeding rate for
PPI immediately after TAVI, Schwerg et al.<sup>[</sup><sup><xref rid="r21" ref-type="bibr">21</xref></sup><sup>]</sup> evaluated patients who have
undergone PPI implantation on the same day of TAVI implant (group A) and
patients in whom the PPI was performed at least 1 day after TAVI (group B)
(3.8&#x000b1;4.5 days). In this study, procedure times, fluid loss via drainage
systems, and drainage times were neither significantly different between the
groups nor when compared to a historical group.</p></sec><sec><title>PPI Risk Factors</title><p>Many factors have been identified for PPI requirement after TAVI, mainly related
to baseline conductions defects, device selection and anatomical
characteristics<sup>[</sup><sup><xref rid="r22" ref-type="bibr">22</xref></sup><sup>]</sup>. Thus, a careful pre-TAVI screening is
overwhelming important<sup>[</sup><sup><xref rid="r19" ref-type="bibr">19</xref></sup><sup>]</sup>.</p><p>Advanced age, permanent atrial fibrillation, use of digoxin, larger or oversized
prosthesis<sup>[</sup><sup><xref rid="r23" ref-type="bibr">23</xref></sup><sup>,</sup><sup><xref rid="r24" ref-type="bibr">24</xref></sup><sup>]</sup>, for example, are considered clinical
predictors for new LBBB post-TAVI, while left heart axis, lower mean heart rate,
and prolonged PQ and QRS times are considered electrocardiographic parameters
for severe cardiac conduction defects requiring PPI in patients with new
LBBB<sup>[</sup><sup><xref rid="r24" ref-type="bibr">24</xref></sup><sup>]</sup>.</p><p>During the procedure predilatation and valve deployment are the most critical
steps for conduction disorders development<sup>[</sup><sup><xref rid="r25" ref-type="bibr">25</xref></sup><sup>,</sup><sup><xref rid="r26" ref-type="bibr">26</xref></sup><sup>]</sup>.</p><p>Regarding the available devices, the differences in shape, height of the frame,
depth of implantation and different physical properties account for the
different PPI incidences observed<sup>[</sup><sup><xref rid="r19" ref-type="bibr">19</xref></sup><sup>]</sup>.</p><p>A meta-analysis published in 2014 with 41 studies comprising 11210 post-TAVI
patients, showed an unadjusted 2.5-fold higher risk for CoreValve&#x000ae; (28%)
compared to Sapien&#x000ae; (6%). The risk was increased for men [relative risk
(RR) 1.23; <italic>P</italic>&#x0003c;0.01]; previous first-degree AVB (RR 1.52;
<italic>P</italic>&#x0003c;0.01), LAHB (RR 1.62; <italic>P</italic>&#x0003c;0.01) or
RBBB (RR 2.89; <italic>P</italic>&#x0003c;0.01) and intraprocedural AVB (RR 3.49;
<italic>P</italic>&#x0003c;0.01)<sup>[</sup><sup><xref rid="r27" ref-type="bibr">27</xref></sup><sup>]</sup>.</p><p>In a more recent study, the combination of pre-TAVI prolonged PR interval
(&#x0003e;220 ms) and increased QRS duration (&#x0003e;120 ms) reached a positive
predictive value for PPI of 80%, suggesting to use such parameters as
periprocedural PPI markers<sup>[</sup><sup><xref rid="r28" ref-type="bibr">28</xref></sup><sup>]</sup>.</p><p>Analyzing national data, the Brazilian Registry of 418 patients with severe AoS
who had undergone TAVI demonstrated a 30-day PPI incidence of 25.2%. On
multivariable analysis only CoreValve&#x000ae; <italic>vs.</italic> Sapien
XT&#x000ae; [odds ratio (OR) 4.24, 95% CI 1.56 - 11.49;
<italic>P</italic>=0.005], baseline RBBB (OR 4.41, 95% CI 2.20 - 8.82;
<italic>P</italic>&#x0003c;0.001), and balloon pre-dilatation (OR 1.75, 95% CI
1.02 - 3.02; <italic>P</italic>=0.04) were independent PPI
predictors<sup>[</sup><sup><xref rid="r29" ref-type="bibr">29</xref></sup><sup>]</sup>.</p><p>Supporting these data, solely baseline RBBB and deep valve implantation were
found as predictors of high-degree AVB and PPI requirement in a separate
multivariable analysis of a study published in 2011 in the American Journal of
Cardiology<sup>[</sup><sup><xref rid="r30" ref-type="bibr">30</xref></sup><sup>]</sup>.</p><p>In terms of potential tools for AVB risk stratification in the
electrophysiological study (EPS), a cohort led by Kostoupoulou et
al.<sup>[</sup><sup><xref rid="r16" ref-type="bibr">16</xref></sup><sup>]</sup> analyzed 30 patients who underwent EPS, 25 of
these had a second EPS after 48h. Delta-HV did not show to be a risk factor and
baseline HV interval did only in univariate analysis.</p><p>Opposing these findings, physicians from the Montreal Heart Institute followed 75
patients who had undergone EPS before and after TAVI. In multivariate analysis,
the delta-HV interval was independently associated with AVB development and its
sensitivity and specificity for predicting AVB were, respectively, 100% and
84.4% for a delta-HV interval &#x02265;13ms<sup>[</sup><sup><xref rid="r31" ref-type="bibr">31</xref></sup><sup>]</sup>.</p><p>Considering the left ventricular outflow tract (LVOT) in terms of amount of
calcium, perimeter and device size relative to LVOT, as well as the degree of
valve protrusion into the LVOT, once these factors could affect the underlying
conduction system, Rodr&#x000ed;guez-Olivares et al.<sup>[</sup><sup><xref rid="r32" ref-type="bibr">32</xref></sup><sup>]</sup> performed a study
where computed tomography was used to assess LVOT. By multivariate analysis RBBB
at baseline (OR 2.9, 95% CI 1.2 - 6.9; <italic>P</italic>=0.014), next
generation valves (OR 2.1, 95% IC 1.0-4.5; <italic>P</italic>=0.048), depth of
implantation (OR 1.2 per 1 mm increment, 95% IC 1.1-1.3;
<italic>P</italic>&#x0003c;0.001) and LVOT sizing (OR per 1% increment 1.0, 95% IC
1.0-1.06; <italic>P</italic>=0.022) were predictors of PPI.</p></sec><sec><title>Heart Block Mechanisms after TAVI</title><p>By Young Lee et al.<sup>[</sup><sup><xref rid="r10" ref-type="bibr">10</xref></sup><sup>]</sup> inter-individual variation in the penetrating
bundle length and depth of septal penetration and variation in the location of
the proximal portion of left bundle determine how susceptible these structures
are to injury during TAVI.</p><p>While conduction abnormalities in surgical aortic valve replacement (SARV) are
attributed to the surgical method - suturing along the sewing ring near the
membranous septum, removal of the native aortic valve and edema - the
susceptibility to AVB in TAVI is more specific.</p><p>In CoreValve&#x000ae;, the AVB risk is partly due to the valve design and the
potential for a deeper valve implantation into the LVOT<sup>[</sup><sup><xref rid="r10" ref-type="bibr">10</xref></sup><sup>]</sup>.</p><p>Kammler et al.<sup>[</sup><sup><xref rid="r33" ref-type="bibr">33</xref></sup><sup>]</sup> identified that the mean distance from the
annular margin of the non-coronary cusp to the ventricular end of the prosthesis
was significantly longer in patients with pacemaker requirement (9.7&#x000b1;4.1
mm <italic>vs</italic>. 6.3&#x000b1;3.4 mm; <italic>P</italic>=0.0017). A cut-off
value of 6 mm predicted this need with a sensitivity of 89% and specificity of
40%.</p><p>Nuis et al.<sup>[</sup><sup><xref rid="r25" ref-type="bibr">25</xref></sup><sup>]</sup> also reported a direct relationship between the
balloon/annulus ratio during balloon valvuloplasty and the development of new
conduction disturbance, with a balloon/annulus ratio close to 1.0 as an
acceptable compromise to avoid it.</p></sec><sec><title>PPI Rates</title><p>PPI after TAVI incidence has been reported ranging from 9% to 42% for
self-expandable valves (CoreValve&#x000ae;) and from 2.5% to 11.5% for balloon
expandable valves (Edwards Sapien&#x000ae;)<sup>[</sup><sup><xref rid="r34" ref-type="bibr">34</xref></sup><sup>]</sup>.</p><p>In the Partner 2 trial, where the Sapien XT&#x000ae; system was used in patients
with severe AoS and intermediate surgical risk, the 30-day PPI rate was
8.5%<sup>[</sup><sup><xref rid="r7" ref-type="bibr">7</xref></sup><sup>]</sup>.</p><p>Comparing two generations of self-expanding repositionable valves, the PPI rates
were 25.5% for CoreValve&#x000ae; and 26.7% for the new generation Evolut
R&#x000ae;<sup>[</sup><sup><xref rid="r8" ref-type="bibr">8</xref></sup><sup>]</sup>.</p><p>In the CHOICE trial, a lower 30-day pos-procedural PPI need was observed in the
balloon-expandable group (Sapien XT&#x000ae;) when compared to the
self-expandable group (CoreValve&#x000ae;) (17.3% <italic>vs.</italic> 37.6%, RR
0.46, 95% CI 0.28 - 0.74). Besides, cardiovascular mortality within 30 days was
4.1% in the first and 4.3% in the second group (RR 0.97, 95% CI 0.29 - 3.25;
<italic>P</italic>=0.99)<sup>[</sup><sup><xref rid="r35" ref-type="bibr">35</xref></sup><sup>]</sup>.</p><p>Another study comparing second generation devices - Direct Flow Medical&#x000ae;,
Lotus&#x000ae;, Evolut R&#x000ae; or Sapien 3&#x000ae; (2G) to first generation -
Sapien XT&#x000ae;, CoreValve&#x000ae; (1G), showed no differences regarding PPI
requirement (6.5% <italic>vs.</italic> 7.8%; <italic>P</italic>=0.46); but
patients treated with 1G devices suffered more 30-day adverse events (free of
adverse events 75.3% <italic>vs.</italic> 88.8%, HR 2.4; 95% CI 1.4 - 4.0;
<italic>P</italic>=0.01)<sup>[</sup><sup><xref rid="r36" ref-type="bibr">36</xref></sup><sup>]</sup>.</p><p>According to access routes, The German aortic valve registry (GARY), the biggest
registry about TAVI, showed that 1-year pacemaker need was 26.2% in
transvascular approach and 14.1% in transapical<sup>[</sup><sup><xref rid="r37" ref-type="bibr">37</xref></sup><sup>]</sup>.</p><p>Finally, in a meta-analysis published in 2016, which compared TAVI with
conventional SVAR in low and intermediate risk patients, a higher PPI rate after
TAVI was observed when compared to SAVR (21.6% <italic>vs.</italic> 7.5%, OR
7.4, 95% CI 1.98 - 8.34; <italic>P</italic>&#x0003c;0.001)<sup>[</sup><sup><xref rid="r38" ref-type="bibr">38</xref></sup><sup>]</sup>. The same finding
has not been seen with sutureless devices, which have a PPI incidence similar to
TAVI (5-17%)<sup>[</sup><sup><xref rid="r39" ref-type="bibr">39</xref></sup><sup>-</sup><sup><xref rid="r42" ref-type="bibr">42</xref></sup><sup>]</sup>.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Not only anatomical variations in each patient conduction system may have an
important role in the conduction disorders prevalence after TAVI, as well as the
different valve implanted and its characteristics in terms of diameter and
relationship with other cardiac structures. Self-expandable devices are related to a
higher incidence of PPI need than balloon-expandable valves.</p><p>Some baseline features, like RBBB, have been confirmed as significant predictors of
PPI need. Moreover, new LBBB, which most often occur in the first 48 hours after
TAVI, may also be a PPI risk factor.</p><p>Further studies may be necessary for better understanding of rhythm abnormalities and
to establish the permanent pacemaker implantation criteria after TAVI.</p><table-wrap id="t3" orientation="portrait" position="float"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">MS</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">APT</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LCD</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">EB</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ANK</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">EKS</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at the Universidade Luterana do Brasil (ULBRA),
Canoas, RS, Brazil and at the Hospital de Cl&#x000ed;nicas de Porto Alegre
(HCPA), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS,
Brazil.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><fn-group><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nkomo</surname><given-names>VT</given-names></name><name><surname>Gardin</surname><given-names>JM</given-names></name><name><surname>Skelton</surname><given-names>TN</given-names></name><name><surname>Gottdiener</surname><given-names>JS</given-names></name><name><surname>Scott</surname><given-names>CG</given-names></name><name><surname>Enriquez-Sarano</surname><given-names>M</given-names></name></person-group><article-title>Burden of valvular heart diseases: a population-based
study</article-title><source>Lancet</source><year>2006</year><volume>368</volume><issue>9540</issue><fpage>1005</fpage><lpage>1011</lpage><pub-id pub-id-type="pmid">16980116</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horstkotte</surname><given-names>D</given-names></name><name><surname>Loogen</surname><given-names>F</given-names></name></person-group><article-title>The natural history of aortic valve stenosis</article-title><source>Eur Heart J</source><year>1988</year><volume>9</volume><issue>Suppl E</issue><fpage>57</fpage><lpage>64</lpage></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>A</given-names></name><name><surname>Ross Jr</surname><given-names>J</given-names></name></person-group><article-title>Natural history of valvular aortic stenosis</article-title><source>Br Heart J</source><year>1973</year><volume>35</volume><issue>1</issue><fpage>41</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">4685905</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Braunwald</surname><given-names>E</given-names></name><name><surname>Zipes</surname><given-names>DP</given-names></name><name><surname>Libby</surname><given-names>P</given-names></name></person-group><source>Braunwald's heart disease: a textbook of cardiovascular
medicine</source><edition>9th ed.</edition><publisher-loc>S&#x000e3;o Paulo</publisher-loc><publisher-name>Roca</publisher-name><year>2003</year></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorgato</surname><given-names>A</given-names></name><name><surname>Faggiano</surname><given-names>P</given-names></name><name><surname>Aurigemma</surname><given-names>GP</given-names></name><name><surname>Rusconi</surname><given-names>C</given-names></name><name><surname>Gaasch</surname><given-names>WH</given-names></name></person-group><article-title>Ventricular arrhythmias in adult aortic stenosis: prevalence,
mechanisms, and clinical relevance</article-title><source>Chest</source><year>1998</year><volume>113</volume><issue>2</issue><fpage>482</fpage><lpage>491</lpage><pub-id pub-id-type="pmid">9498969</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cribier</surname><given-names>A</given-names></name><name><surname>Eltchaninoff</surname><given-names>H</given-names></name><name><surname>Bash</surname><given-names>A</given-names></name><name><surname>Borenstein</surname><given-names>N</given-names></name><name><surname>Tron</surname><given-names>C</given-names></name><name><surname>Bauer</surname><given-names>F</given-names></name><etal/></person-group><article-title>Percutaneous transcatheter implantation of an aortic valve
prosthesis for calcific aortic stenosis: first human case
description</article-title><source>Circulation</source><year>2002</year><volume>106</volume><issue>24</issue><fpage>3006</fpage><lpage>3008</lpage><pub-id pub-id-type="pmid">12473543</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leon</surname><given-names>MB</given-names></name><name><surname>Smith</surname><given-names>CR</given-names></name><name><surname>Mack</surname><given-names>MJ</given-names></name><name><surname>Makkar</surname><given-names>RR</given-names></name><name><surname>Mumtaz</surname><given-names>M</given-names></name><name><surname>Adams</surname><given-names>DH</given-names></name><etal/></person-group><article-title>Transcatheter or surgical aortic-valve replacement in
intermediate-risk patients</article-title><source>N Engl J Med</source><year>2017</year><volume>376</volume><issue>14</issue><fpage>1321</fpage><lpage>1331</lpage><pub-id pub-id-type="pmid">28304219</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reardon</surname><given-names>MJ</given-names></name><name><surname>Van Mieghem</surname><given-names>NM</given-names></name><name><surname>Popma</surname><given-names>JJ</given-names></name><name><surname>Kleiman</surname><given-names>NS</given-names></name><name><surname>S&#x000f8;ndergaard</surname><given-names>L</given-names></name><name><surname>Mumtaz</surname><given-names>M</given-names></name><etal/><collab>SURTAVI Investigators</collab></person-group><article-title>Surgical or transcatheter aortic-valve replacement in
intermediate-risk patients</article-title><source>N Engl J Med</source><year>2017</year><volume>376</volume><issue>14</issue><fpage>1321</fpage><lpage>1331</lpage><pub-id pub-id-type="pmid">28304219</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000f8;ndergaard</surname><given-names>L</given-names></name><name><surname>Steinbr&#x000fc;chel</surname><given-names>DA</given-names></name><name><surname>Ihlemann</surname><given-names>N</given-names></name><name><surname>Nissen</surname><given-names>H</given-names></name><name><surname>Kjeldsen</surname><given-names>BJ</given-names></name><name><surname>Petursson</surname><given-names>P</given-names></name><etal/></person-group><article-title>Two-year outcomes in patients with severe aortic valve stenosis
randomized to transcatheter versus surgical aortic valve replacement: The
All-Comers Nordic Aortic Valve Intervention Randomized Clinical
Trial</article-title><source>Circ Cardiovasc Interv</source><year>2016</year><volume>9</volume><issue>6</issue><!--<pub-id pub-id-type="pii">e003665</pub-id>--></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young Lee</surname><given-names>M</given-names></name><name><surname>Chilakamarri Yeshwant</surname><given-names>S</given-names></name><name><surname>Chava</surname><given-names>S</given-names></name><name><surname>Lawrence Lustgarten</surname><given-names>D</given-names></name></person-group><article-title>Mechanisms of heart block after transcatheter aortic valve
replacement - cardiac anatomy, clinical predictors and mechanical factors
that contribute to permanent pacemaker implantation</article-title><source>Arrhythm Electrophysiol Rev</source><year>2015</year><volume>4</volume><issue>2</issue><fpage>81</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">26835105</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>European Society of Cardiology (ESC)1</collab><collab>European Heart Rhythm Association (EHRA)</collab><name><surname>Brignole</surname><given-names>M</given-names></name><name><surname>Auricchio</surname><given-names>A</given-names></name><name><surname>Baron-Esquivias</surname><given-names>G</given-names></name><name><surname>Bordachar</surname><given-names>P</given-names></name><name><surname>Boriani</surname><given-names>G</given-names></name><name><surname>Breithardt</surname><given-names>OA</given-names></name><etal/></person-group><article-title>2013 ESC guidelines on cardiac pacing and cardiac
resynchronization therapy: the task force on cardiac pacing and
resynchronization therapy of the European Society of Cardiology (ESC).
Developed in collaboration with the European Heart Rhythm Association
(EHRA)</article-title><source>Europace</source><year>2013</year><volume>15</volume><issue>8</issue><fpage>1070</fpage><lpage>1118</lpage><pub-id pub-id-type="pmid">23801827</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orlando</surname><given-names>R</given-names></name><name><surname>Pennant</surname><given-names>M</given-names></name><name><surname>Rooney</surname><given-names>S</given-names></name><name><surname>Khogali</surname><given-names>S</given-names></name><name><surname>Bayliss</surname><given-names>S</given-names></name><name><surname>Hassan</surname><given-names>A</given-names></name><etal/></person-group><article-title>Cost-effectiveness of transcatheter aortic valve implantation
(TAVI) for aortic stenosis in patients who are high risk or contraindicated
for surgery: a model-based economic evaluation</article-title><source>Health Technol Assess</source><year>2013</year><volume>17</volume><issue>33</issue><fpage>1</fpage><lpage>86</lpage></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urena</surname><given-names>M</given-names></name><name><surname>Mok</surname><given-names>M</given-names></name><name><surname>Serra</surname><given-names>V</given-names></name><name><surname>Dumont</surname><given-names>E</given-names></name><name><surname>Nombela-Franco</surname><given-names>L</given-names></name><name><surname>DeLarochelli&#x000e8;re</surname><given-names>R</given-names></name><etal/></person-group><article-title>Predictive factors and long-term clinical consequences of
persistent left bundle branch block following transcatheter aortic valve
implantation with a balloon-expandable valve</article-title><source>J Am Coll Cardiol</source><year>2012</year><volume>60</volume><issue>18</issue><fpage>1743</fpage><lpage>1752</lpage><pub-id pub-id-type="pmid">23040577</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Testa</surname><given-names>L</given-names></name><name><surname>Latib</surname><given-names>A</given-names></name><name><surname>De Marco</surname><given-names>F</given-names></name><name><surname>De Carlo</surname><given-names>M</given-names></name><name><surname>Agnifili</surname><given-names>M</given-names></name><name><surname>Latini</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Clinical impact of persistent left bundle-branch block after
transcatheter aortic valve implantation with CoreValve Revalving
System</article-title><source>Circulation</source><year>2013</year><volume>127</volume><issue>12</issue><fpage>1300</fpage><lpage>1307</lpage><pub-id pub-id-type="pmid">23443735</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houthuizen</surname><given-names>P</given-names></name><name><surname>Van Garsse</surname><given-names>LA</given-names></name><name><surname>Poels</surname><given-names>TT</given-names></name><name><surname>de Jaegere</surname><given-names>P</given-names></name><name><surname>van der Boon</surname><given-names>RM</given-names></name><name><surname>Swinkels</surname><given-names>BM</given-names></name><etal/></person-group><article-title>Left bundle-branch block induced by transcatheter aortic valve
implantation increases risk of death</article-title><source>Circulation</source><year>2012</year><volume>126</volume><issue>6</issue><fpage>720</fpage><lpage>728</lpage><pub-id pub-id-type="pmid">22791865</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostopoulou</surname><given-names>A</given-names></name><name><surname>Karyofillis</surname><given-names>P</given-names></name><name><surname>Livanis</surname><given-names>E</given-names></name><name><surname>Thomopoulou</surname><given-names>S</given-names></name><name><surname>Stefopoulos</surname><given-names>C</given-names></name><name><surname>Doudoumis</surname><given-names>K</given-names></name><etal/></person-group><article-title>pacing after transcatheter aortic valve implantation of a
CoreValve prosthesis as determined by electrocardiographic and
electrophysiological predictors : a single-center experience</article-title><source>Europace</source><year>2016</year><volume>18</volume><issue>1</issue><fpage>131</fpage><lpage>137</lpage><pub-id pub-id-type="pmid">26060209</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazif</surname><given-names>TM</given-names></name><name><surname>Williams</surname><given-names>MR</given-names></name><name><surname>Hahn</surname><given-names>RT</given-names></name><name><surname>Kapadia</surname><given-names>S</given-names></name><name><surname>Babaliaros</surname><given-names>V</given-names></name><name><surname>Rod&#x000e9;s-Cabau</surname><given-names>J</given-names></name><etal/></person-group><article-title>Clinical implications of new-onset left bundle branch block after
transcatheter aortic valve replacement : analysis of the PARTNER
experience</article-title><source>Eur Heart J</source><year>2014</year><volume>35</volume><issue>24</issue><fpage>1599</fpage><lpage>1607</lpage><pub-id pub-id-type="pmid">24179072</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makki</surname><given-names>N</given-names></name><name><surname>Dollery</surname><given-names>J</given-names></name><name><surname>Jones</surname><given-names>D</given-names></name><name><surname>Crestanello</surname><given-names>J</given-names></name><name><surname>Lilly</surname><given-names>S</given-names></name></person-group><article-title>Conduction disturbance after TAVR: Electrophysiological studies
and pacemaker dependency</article-title><source>Cardiovasc Revasc Med</source><year>2017</year><volume>18</volume><issue>5S1</issue><fpage>S10</fpage><lpage>S13</lpage><pub-id pub-id-type="pmid">28377313</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fraccaro</surname><given-names>C</given-names></name><name><surname>Napodano</surname><given-names>M</given-names></name><name><surname>Tarantini</surname><given-names>G</given-names></name></person-group><article-title>Conduction disorders in the setting of transcatheter aortic valve
implantation: a clinical perspective</article-title><source>Catheter Cardiovasc Interv</source><year>2013</year><volume>81</volume><issue>7</issue><fpage>1217</fpage><lpage>1223</lpage><pub-id pub-id-type="pmid">23456893</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Mouillet</surname><given-names>G</given-names></name><name><surname>Deballon</surname><given-names>R</given-names></name><name><surname>Sudre</surname><given-names>A</given-names></name><name><surname>Lellouche</surname><given-names>N</given-names></name><name><surname>Lim</surname><given-names>P</given-names></name><etal/></person-group><article-title>Impact of QRS duration on decision of early removal of pacing
catheter after transcatheter aortic valve replacement with Corevalve
device</article-title><source>Am J Cardiol</source><year>2017</year><volume>120</volume><issue>5</issue><fpage>838</fpage><lpage>843</lpage><pub-id pub-id-type="pmid">28688703</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwerg</surname><given-names>M</given-names></name><name><surname>Baldenhofer</surname><given-names>G</given-names></name><name><surname>Dreger</surname><given-names>H</given-names></name><name><surname>Bondke</surname><given-names>H</given-names></name><name><surname>Stangl</surname><given-names>K</given-names></name><name><surname>Laule</surname><given-names>M</given-names></name><etal/></person-group><article-title>Complete atrioventricular block after TAVI: when is pacemaker
implantation safe?</article-title><source>Pacing Clin Electrophysiol</source><year>2013</year><volume>36</volume><issue>7</issue><fpage>898</fpage><lpage>903</lpage><pub-id pub-id-type="pmid">23607531</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDonnell</surname><given-names>KM</given-names></name><name><surname>Shepard</surname><given-names>RK</given-names></name></person-group><article-title>Conduction disorders after transcatheter aortic valve
implantation: a focused review</article-title><source>Curr Treat Options Cardiovasc Med</source><year>2013</year><volume>15</volume><issue>4</issue><fpage>488</fpage><lpage>496</lpage><pub-id pub-id-type="pmid">23637020</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroeter</surname><given-names>T</given-names></name><name><surname>Linke</surname><given-names>A</given-names></name><name><surname>Haensig</surname><given-names>M</given-names></name><name><surname>Merk</surname><given-names>DR</given-names></name><name><surname>Borger</surname><given-names>MA</given-names></name><name><surname>Mohr</surname><given-names>FW</given-names></name><etal/></person-group><article-title>Predictors of permanent pacemaker implantation after Medtronic
CoreValve bioprosthesis implantation</article-title><source>Europace</source><year>2012</year><volume>14</volume><issue>12</issue><fpage>1759</fpage><lpage>1763</lpage><pub-id pub-id-type="pmid">22733983</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nijenhuis</surname><given-names>VJ</given-names></name><name><surname>Van Dijk</surname><given-names>VF</given-names></name><name><surname>Chaldoupi</surname><given-names>SM</given-names></name><name><surname>Balt</surname><given-names>JC</given-names></name><name><surname>Ten Berg</surname><given-names>JM</given-names></name></person-group><article-title>Severe conduction defects requiring permanent pacemaker
implantation in patients with a new-onset left bundle branch block after
transcatheter aortic valve implantation</article-title><source>Europace</source><year>2017</year><volume>19</volume><issue>6</issue><fpage>1015</fpage><lpage>1021</lpage><pub-id pub-id-type="pmid">28340150</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nuis</surname><given-names>R</given-names></name><name><surname>Van Mieghem</surname><given-names>NM</given-names></name><name><surname>Schultz</surname><given-names>CJ</given-names></name><name><surname>Tzikas</surname><given-names>A</given-names></name><name><surname>Van der Boon</surname><given-names>RM</given-names></name><name><surname>Maugenest</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Timing and potential mechanisms of new conduction abnormalities
during the implantation of the Medtronic CoreValve System in patients with
aortic stenosis</article-title><source>Eur Heart J</source><year>2011</year><volume>32</volume><issue>16</issue><fpage>2067</fpage><lpage>2074</lpage><pub-id pub-id-type="pmid">21622979</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roten</surname><given-names>L</given-names></name><name><surname>Stortecky</surname><given-names>S</given-names></name><name><surname>Scarcia</surname><given-names>F</given-names></name><name><surname>Kadner</surname><given-names>A</given-names></name><name><surname>Tanner</surname><given-names>H</given-names></name><name><surname>Delacr&#x000e9;taz</surname><given-names>E</given-names></name><etal/></person-group><article-title>Atrioventricular conduction after transcatheter aortic valve
implantation and surgical aortic valve replacement</article-title><source>J Cardiovasc Electrophysiol</source><year>2012</year><volume>23</volume><issue>10</issue><fpage>1115</fpage><lpage>1122</lpage><pub-id pub-id-type="pmid">22587564</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siontis</surname><given-names>GC</given-names></name><name><surname>J&#x000fc;ni</surname><given-names>P</given-names></name><name><surname>Pilgrim</surname><given-names>T</given-names></name><name><surname>Stortecky</surname><given-names>S</given-names></name><name><surname>B&#x000fc;llesfeld</surname><given-names>L</given-names></name><name><surname>Meier</surname><given-names>B</given-names></name><etal/></person-group><article-title>Predictors of permanent pacemaker implantation in patients with
severe aortic stenosis undergoing TAVR: a meta-analysis</article-title><source>J Am Coll Cardiol</source><year>2014</year><volume>64</volume><issue>2</issue><fpage>129</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">25011716</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>M</given-names></name><name><surname>Blangy</surname><given-names>H</given-names></name><name><surname>Folliguet</surname><given-names>T</given-names></name><name><surname>Villemin</surname><given-names>T</given-names></name><name><surname>Freysz</surname><given-names>L</given-names></name><name><surname>Luc</surname><given-names>A</given-names></name><etal/></person-group><article-title>Incidence, indications and predicting factors of permanent
pacemaker implantation after transcatheter aortic valve implantation: a
retrospective study</article-title><source>Arch Cardiovasc Dis</source><year>2017</year><volume>110</volume><issue>10</issue><fpage>508</fpage><lpage>516</lpage><pub-id pub-id-type="pmid">28647466</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gensas</surname><given-names>CS</given-names></name><name><surname>Caixeta</surname><given-names>A</given-names></name><name><surname>Siqueira</surname><given-names>D</given-names></name><name><surname>Carvalho</surname><given-names>LA</given-names></name><name><surname>Sarmento-Leite</surname><given-names>R</given-names></name><name><surname>Mangione</surname><given-names>JA</given-names></name><etal/><collab>Brazilian Registry in Transcatheter Aortic Valve Implantation
Investigators</collab></person-group><article-title>Predictors of permanent pacemaker requirement after transcatheter
aortic valve implantation: insights from a Brazilian
registry</article-title><source>Int J Cardiol</source><year>2014</year><volume>175</volume><issue>2</issue><fpage>248</fpage><lpage>252</lpage><pub-id pub-id-type="pmid">24880480</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guetta</surname><given-names>V</given-names></name><name><surname>Goldenberg</surname><given-names>G</given-names></name><name><surname>Segev</surname><given-names>A</given-names></name><name><surname>Dvir</surname><given-names>D</given-names></name><name><surname>Kornowski</surname><given-names>R</given-names></name><name><surname>Finckelstein</surname><given-names>A</given-names></name><etal/></person-group><article-title>Predictors and course of high-degree atrioventricular block after
transcatheter aortic valve implantation using the CoreValve Revalving
System</article-title><source>Am J Cardiol</source><year>2011</year><volume>108</volume><issue>11</issue><fpage>1600</fpage><lpage>1605</lpage><pub-id pub-id-type="pmid">21880290</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivard</surname><given-names>L</given-names></name><name><surname>Schram</surname><given-names>G</given-names></name><name><surname>Asgar</surname><given-names>A</given-names></name><name><surname>Khairy</surname><given-names>P</given-names></name><name><surname>Andrade</surname><given-names>JG</given-names></name><name><surname>Bonan</surname><given-names>R</given-names></name><etal/></person-group><article-title>Electrocardiographic and electrophysiological predictors of
atrioventricular block after transcatheter aortic valve
replacement</article-title><source>Heart Rhythm</source><year>2015</year><volume>12</volume><issue>2</issue><fpage>321</fpage><lpage>329</lpage><pub-id pub-id-type="pmid">25446155</pub-id></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ed;guez-Olivares</surname><given-names>R</given-names></name><name><surname>van Gils</surname><given-names>L</given-names></name><name><surname>El Faquir</surname><given-names>N</given-names></name><name><surname>Rahhab</surname><given-names>Z</given-names></name><name><surname>Di Martino</surname><given-names>LF</given-names></name><name><surname>van Weenen</surname><given-names>S</given-names></name><etal/></person-group><article-title>Importance of the left ventricular outflow tract in the need for
pacemaker implantation after transcatheter aortic valve
replacement</article-title><source>Int J Cardiol</source><year>2016</year><volume>216</volume><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">27135150</pub-id></element-citation></ref><ref id="r33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kammler</surname><given-names>J</given-names></name><name><surname>Blessberger</surname><given-names>H</given-names></name><name><surname>Fellner</surname><given-names>F</given-names></name><name><surname>Kypta</surname><given-names>A</given-names></name><name><surname>Lambert</surname><given-names>T</given-names></name><name><surname>Engl</surname><given-names>M</given-names></name><etal/></person-group><article-title>Implantation depth measured by 64-slice computed tomography is
associated with permanent pacemaker requirement following transcatheter
aortic valve implantation with the Core Valve&#x000ae; system</article-title><source>J Cardiol</source><year>2016</year><volume>67</volume><issue>6</issue><fpage>513</fpage><lpage>518</lpage><pub-id pub-id-type="pmid">26826937</pub-id></element-citation></ref><ref id="r34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagur</surname><given-names>R</given-names></name><name><surname>Rod&#x000e9;s-Cabau</surname><given-names>J</given-names></name><name><surname>Gurvitch</surname><given-names>R</given-names></name><name><surname>Dumont</surname><given-names>&#x000c9;</given-names></name><name><surname>Velianou</surname><given-names>JL</given-names></name><name><surname>Manazzoni</surname><given-names>J</given-names></name><etal/></person-group><article-title>Need for permanent pacemaker as a complication of transcatheter
aortic valve implantation and surgical aortic valve replacement in elderly
patients with severe aortic stenosis and similar baseline
electrocardiographic findings</article-title><source>JACC Cardiovasc Interv</source><year>2012</year><volume>5</volume><issue>5</issue><fpage>540</fpage><lpage>551</lpage><pub-id pub-id-type="pmid">22625193</pub-id></element-citation></ref><ref id="r35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdel-Wahab</surname><given-names>M</given-names></name><name><surname>Mehilli</surname><given-names>J</given-names></name><name><surname>Frerker</surname><given-names>C</given-names></name><name><surname>Neumann</surname><given-names>FJ</given-names></name><name><surname>Kurz</surname><given-names>T</given-names></name><name><surname>T&#x000f6;lg</surname><given-names>R</given-names></name><etal/><collab>CHOICE investigators</collab></person-group><article-title>Comparison of balloon-expandable vs self-expandable valves in
patients undergoing transcatheter aortic valve replacement: the CHOICE
randomized clinical trial</article-title><source>Jama</source><year>2014</year><volume>311</volume><issue>15</issue><fpage>1503</fpage><lpage>1514</lpage><pub-id pub-id-type="pmid">24682026</pub-id></element-citation></ref><ref id="r36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruparelia</surname><given-names>N</given-names></name><name><surname>Latib</surname><given-names>A</given-names></name><name><surname>Kawamoto</surname><given-names>H</given-names></name><name><surname>Buzzatti</surname><given-names>N</given-names></name><name><surname>Giannini</surname><given-names>F</given-names></name><name><surname>Figini</surname><given-names>F</given-names></name><etal/></person-group><article-title>A Comparison between first-generation and second-generation
transcatheter aortic valve implantation (TAVI) devices: a propensity-matched
single-center experience</article-title><source>J Invasive Cardiol</source><year>2016</year><volume>28</volume><issue>5</issue><fpage>210</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">27145054</pub-id></element-citation></ref><ref id="r37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohr</surname><given-names>FW</given-names></name><name><surname>Holzhey</surname><given-names>D</given-names></name><name><surname>M&#x000f6;llmann</surname><given-names>H</given-names></name><name><surname>Beckmann</surname><given-names>A</given-names></name><name><surname>Veit</surname><given-names>C</given-names></name><name><surname>Figulla</surname><given-names>HR</given-names></name><etal/></person-group><article-title>The German Aortic Valve Registry: 1-year results from 13,680
patients with aortic valve disease</article-title><source>Eur J Cardiothorac Surg</source><year>2014</year><volume>46</volume><issue>5</issue><fpage>808</fpage><lpage>806</lpage><pub-id pub-id-type="pmid">25079769</pub-id></element-citation></ref><ref id="r38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondur</surname><given-names>A</given-names></name><name><surname>Briasoulis</surname><given-names>A</given-names></name><name><surname>Palla</surname><given-names>M</given-names></name><name><surname>Penumetcha</surname><given-names>A</given-names></name><name><surname>Mallikethi-Reddy</surname><given-names>S</given-names></name><name><surname>Badheka</surname><given-names>A</given-names></name><etal/></person-group><article-title>Meta-analysis of transcatheter aortic valve replacement versus
surgical aortic valve replacement in patients with severe aortic valve
stenosis</article-title><source>Am J Cardiol</source><year>2016</year><volume>117</volume><issue>2</issue><fpage>252</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">26639040</pub-id></element-citation></ref><ref id="r39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tagliari</surname><given-names>AP</given-names></name><name><surname>Moura</surname><given-names>L</given-names></name><name><surname>Dussin</surname><given-names>LH</given-names></name><name><surname>Saadi</surname><given-names>EK</given-names></name></person-group><article-title>Sutureless aortic prosthesis implantation: the first Brazilian
experience with Perceval device</article-title><source>Brazilian J Cardiovasc Surg</source><year>2016</year><volume>31</volume><issue>4</issue><fpage>334</fpage><lpage>336</lpage></element-citation></ref><ref id="r40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazine</surname><given-names>A</given-names></name><name><surname>Teoh</surname><given-names>K</given-names></name><name><surname>Bouhout</surname><given-names>I</given-names></name><name><surname>Bhatnagar</surname><given-names>G</given-names></name><name><surname>Pelletier</surname><given-names>M</given-names></name><name><surname>Voisine</surname><given-names>P</given-names></name><etal/></person-group><article-title>Sutureless aortic valve replacement: a Canadian multicentre
study</article-title><source>Can J Cardiol</source><year>2015</year><volume>31</volume><issue>1</issue><fpage>63</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">25547552</pub-id></element-citation></ref><ref id="r41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shrestha</surname><given-names>M</given-names></name><name><surname>Fischlein</surname><given-names>T</given-names></name><name><surname>Meuris</surname><given-names>B</given-names></name><name><surname>Flameng</surname><given-names>W</given-names></name><name><surname>Carrel</surname><given-names>T</given-names></name><name><surname>Madonna</surname><given-names>F</given-names></name><etal/></person-group><article-title>European multicentre experience with the sutureless Perceval
valve: clinical and haemodynamic outcomes up to 5 years</article-title><source>Eur J Cardiothorac Surg</source><year>2016</year><volume>49</volume><issue>1</issue><fpage>234</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">25750010</pub-id></element-citation></ref><ref id="r42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zannis</surname><given-names>K</given-names></name><name><surname>Joffre</surname><given-names>J</given-names></name><name><surname>Czitrom</surname><given-names>D</given-names></name><name><surname>Folliguet</surname><given-names>T</given-names></name><name><surname>Noghin</surname><given-names>M</given-names></name><name><surname>Lansac</surname><given-names>MN</given-names></name><etal/></person-group><article-title>Aortic valve replacement with the perceval S bioprosthesis:
single-center experience in 143 patients</article-title><source>J Heart Valve Dis</source><year>2014</year><volume>23</volume><issue>6</issue><fpage>795</fpage><lpage>802</lpage><pub-id pub-id-type="pmid">25790630</pub-id></element-citation></ref></ref-list></back></article>